MRVI Stock Analysis: Buy, Sell, or Hold?

MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$6.27
0.17 (2.87%) ▲
5d: +6.19%
30d: +23.33%
90d: +104.07%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 10, 2026 27d

Get Alerted When MRVI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: MRVI shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MRVI is currently trading at $6.26, which is considered extended relative to its 30-day fair value range of $5.08 to $6.09.

Technical Outlook: Technically, MRVI is in a strong uptrend. The price is approaching resistance at $5.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $5.08 - $6.09
Company Quality Score 60/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 43.2%

All Signals

  • BEARISH: Price extended above range
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading above Wall St target ($5.70)

Trading Range Analysis

30-Day Trading Range $5.08 - $6.09
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $4.34
Resistance Level $5.21
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -65.48
Wall Street Target $5.70 (-6.4%)
Revenue Growth (YoY) 40.5%
Earnings Growth (YoY) -32.7%
Profit Margin -51.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 13, 2026 12:44 PM ET
Data refreshes hourly during market hours. Next update: 1:44 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MRVI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$441 62 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 61 BUY
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 62 BUY
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 64 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$32 63 BUY

More Analysis for MRVI

MRVI Technical Chart MRVI Price Prediction MRVI Earnings Date MRVI Investment Advisor MRVI Fair Price Analyzer MRVI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals